LOAMU
AVDL

Lombard Odier Asset Management (USA)’s Avadel Pharmaceuticals AVDL Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-220,000
Closed -$2.69M – 159
2015
Q4 		$2.69M Buy
220,000
+26,753
+14% +$417K 0.26% 110
2015
Q3 		$3.15M Sell
193,247
-141,753
-42% -$3.12M 0.28% 115
2015
Q2 		$7.1M Buy
+335,000
New +$6.01M 0.5% 56

Other funds holding AVDL

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return
FPC
Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s AVDL Position: Q1 2016 in Review

Lombard Odier Asset Management (USA) sold out of Avadel Pharmaceuticals (AVDL) in Q1 2016, closing a stake of 220,000 shares — an estimated $2.69M sold.

Lombard Odier Asset Management (USA) first reported a position in AVDL in Q2 2015 and held it in 3 quarters. The position peaked at $7.1M in Q2 2015. 81 funds tracked by Wall St. Rank hold AVDL as of Q1 2016.

  • Lombard Odier Asset Management (USA) reported no remaining Avadel Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 220,000 Avadel Pharmaceuticals shares in Q1 2016, an estimated $2.69M.
  • Lombard Odier Asset Management (USA) first reported a position in Avadel Pharmaceuticals in Q2 2015 and held it in 3 quarters.
  • Lombard Odier Asset Management (USA)'s Avadel Pharmaceuticals position peaked at $7.1M in Q2 2015.
  • 81 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2016.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q1 2016, filed 16 May 2016.